Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Adamas Pharmaceuticals ADS-5102 PDUFA

Adamas Pharmaceuticals (ADMS) Levodopa-Induced Dyskinesia drug ADS-5102 decision is expected any time now. 

Approval is highly likely.